Lipella Pharmaceuticals Inc. Common Stock (LIPO) — Defensive Interval Ratio
Lipella Pharmaceuticals Inc. Common Stock (LIPO) has a Defensive Interval Ratio of 21 days as of June 2025. Defensive assets of $41.98K (cash $-, short-term investments $-, receivables $41.98K) cover 21 days of daily cash needs of $2.05K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Lipella Pharmaceuticals Inc. Common Stock Defensive Interval Ratio (2019–2024)
This chart shows how Lipella Pharmaceuticals Inc. Common Stock's Defensive Interval Ratio has evolved across 6 annual periods from 2019 to 2024. As of June 2025, the ratio stands at 21 days, meaning defensive assets of $41.98K can fund 21 days of operations without new revenue. For the complete balance sheet picture, see Lipella Pharmaceuticals Inc. Common Stoc (LIPO) total assets.
Annual Defensive Interval Ratio for Lipella Pharmaceuticals Inc. Common Stock (2019–2024)
The table below presents the year-by-year Defensive Interval Ratio for Lipella Pharmaceuticals Inc. Common Stock from 2019 to 2024, covering 6 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See Lipella Pharmaceuticals Inc. Common Stoc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 1056058 days | $2.18 Billion | $2.07K/day | $- | $2.18 Billion | ▲ +1056028 days |
| 2023 | 31 days | $32.29K | $1.06K/day | $- | $- | ▼ -5 days |
| 2022 | 35 days | $113.66K | $3.23K/day | $- | $0.00 | ▼ -287 days |
| 2021 | 322 days | $300.55K | $933.22/day | $- | $300.55K | ▲ +201 days |
| 2020 | 121 days | $69.03K | $569.23/day | $- | $0.00 | ▼ -64 days |
| 2019 | 185 days | $83.89K | $453.90/day | $- | $- | — |